Effects of Arimidex on Oestradiol in Post-Menopausal Women
Author Information
Author(s): RA Yates, M Dowsett, GV Fisher, A Selen, PJ Wyld
Primary Institution: Zeneca Pharmaceuticals
Hypothesis
What is the pharmacokinetic profile and effect of Arimidex on oestradiol levels in post-menopausal women?
Conclusion
Arimidex significantly reduces serum oestradiol levels in post-menopausal women without affecting other steroid hormones.
Supporting Evidence
- Mean serum oestradiol concentrations decreased by approximately 70% compared to placebo by 48 hours after the first dose.
- After multiple doses, oestradiol concentrations were suppressed by 80% compared to baseline.
- 1.0 mg of ZD1033 was found to be the minimal dose required for maximal suppression of oestradiol.
Takeaway
Arimidex is a medicine that helps lower a hormone called oestradiol in women who have stopped having periods, which can help treat breast cancer.
Methodology
Two randomized, double-blind, placebo-controlled studies were conducted with healthy post-menopausal women to assess the effects of Arimidex on oestradiol levels.
Limitations
The studies had a small sample size and were limited to healthy post-menopausal women.
Participant Demographics
Healthy post-menopausal female volunteers aged 45 to 62 years.
Statistical Information
P-Value
0.001
Confidence Interval
(0.52, 2.30)
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website